Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
In cystic fibrosis, thick mucus blocks the pancreatic ducts, so the enzymes needed to break down dietary fat never reach the small intestine, and without that fat digestion the vitamins A, D, E, and K cannot be absorbed. This is why standard multivitamins often fail and why pancreatic enzyme replacement therapy paired with CF-specific, water-miscible vitamin formulations is used, with dosing matched to every meal and snack, plus regular blood level monitoring to catch deficiency or toxicity. Dosage needs shift with age, genotype, liver involvement, bile acid loss, and modulator therapy, so there are several important factors to consider before changing any regimen: see below for the full explanation. Because early signs like night blindness, easy bruising, bone pain, poor weight gain, or greasy stools overlap with many other conditions, a structured review of your symptoms is the fastest way to know whether malabsorption is the likely driver. Take a free, instant, online symptom check to better understand what may be happening and to plan clear next steps with your care team.
Last reviewed for medical accuracy: 08/18/2026
Cystic fibrosis (CF) is a genetic condition that affects the lungs, digestive system and other organs. One major challenge for many people with CF is pancreatic insufficiency, where the pancreas can’t release enough digestive enzymes. Without these enzymes, the body struggles to absorb fat and the fat-soluble vitamins A, D, E and K. Over time, this malabsorption can lead to serious health concerns, including weakened bones and rickets in children.
Fat-soluble vitamins play key roles in how our bodies function:
When these vitamins aren’t absorbed properly, even a balanced diet may not meet the body’s needs.
In CF, thick mucus clogs the pancreatic ducts. This blocks digestive enzymes—especially lipase, which breaks down fats—from reaching the small intestine. The result is:
People with CF and pancreatic insufficiency may notice:
These symptoms can develop gradually. Regular monitoring of vitamin levels helps catch deficiencies early.
Given the critical role of pancreatic enzymes in fat absorption, Pancreatic Enzyme Replacement Therapy (PERT) is standard care for people with CF and pancreatic insufficiency. PERT involves taking enzyme capsules with each meal and snack.
By restoring these enzymes, PERT:
To make the most of PERT:
Even with PERT, additional vitamin supplementation is often necessary. CF care guidelines recommend routine blood tests to check levels of A, D, E and K. Based on results:
Supplements come in water-dispersible or emulsified forms that enhance absorption when mixed with PERT.
Rickets is a condition where growing bones become soft and weak. In CF, it usually stems from vitamin D and calcium malabsorption. To guard against rickets:
Weight-bearing exercises, like walking or light resistance work, also stimulate bone strength.
Managing fat-soluble vitamin malabsorption in CF is a team effort. Your CF care team may include:
Together, you’ll:
In addition to PERT and supplements, consider these practical strategies:
If you experience any of the following, don’t wait to get medical advice:
You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to see what issues could be contributing to your symptoms.
Fat-soluble vitamin malabsorption in cystic fibrosis with pancreatic insufficiency is a common but manageable challenge. Through consistent use of PERT, targeted supplementation and close monitoring, you can maintain healthy vitamin levels, protect against rickets, and support overall health.
Always speak to a doctor or CF specialist about any concerns—especially if you notice symptoms that could be serious. Regular check-ups, open communication and a personalized care plan will help you stay on top of nutrition and bone health throughout life.
(References)
* Wilson DC, Pencharz PB. Nutrition and cystic fibrosis. Nutrition. 1998 Oct;14(10):792-5. doi: 10.1016/s0899-9007(98)00086-0. PMID: 9785364.
* Wier HA, Kuhn RJ. Pancreatic enzyme supplementation. Curr Opin Pediatr. 2011 Oct;23(5):541-4. doi: 10.1097/MOP.0b013e32834a1b33. PMID: 21799412.
* Dodge JA. Pancreatic enzymes and Fibrosing Colonopathy. J Cyst Fibros. 2015 Jan;14(1):153. doi: 10.1016/j.jcf.2014.09.002. Epub 2014 Sep 18. PMID: 25242743.
* Lenglinger J, Hädrich M. Exokrine Pankreasinsuffizienz. Ther Umsch. 2016 Nov;73(9):500-504. doi: 10.1024/0040-5930/a000825. PMID: 27805488.
* Slae M, Wilschanski M. 3.22 Nutrition in Cystic Fibrosis. World Rev Nutr Diet. 2022;124:374-381. doi: 10.1159/000517004. Epub 2022 Mar 3. PMID: 35240644.
* Jia S, Taylor-Cousar JL. Cystic Fibrosis Modulator Therapies. Annu Rev Med. 2023 Jan 27;74:413-426. doi: 10.1146/annurev-med-042921-021447. Epub 2022 Aug 16. PMID: 35973718.
* Mariotti Zani E, Grandinetti R, Cunico D, Torelli L, Fainardi V, Pisi G, Esposito S. Nutritional Care in Children with Cystic Fibrosis. Nutrients. 2023 Jan 17;15(3). doi: 10.3390/nu15030479. Epub 2023 Jan 17. PMID: 36771186; PMCID: PMC9921127.
* Whitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology. 2023 Nov;165(5):1292-1301. doi: 10.1053/j.gastro.2023.07.007. Epub 2023 Sep 20. PMID: 37737818.
* Wilschanski M, Munck A, Carrion E, Cipolli M, Collins S, Colombo C, Declercq D, Hatziagorou E, Hulst J, Kalnins D, Katsagoni CN, Mainz JG, Ribes-Koninckx C, Smith C, Smith T, Van Biervliet S, Chourdakis M. ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis. Clin Nutr. 2024 Feb;43(2):413-445. doi: 10.1016/j.clnu.2023.12.017. Epub 2023 Dec 27. PMID: 38169175.
* Dominguez-Muñoz JE, Vujasinovic M, de la Iglesia D, Cahen D, Capurso G, Gubergrits N, Hegyi P, Hungin P, Ockenga J, Paiella S, Perkhofer L, Rebours V, Rosendahl J, Salvia R, Scheers I, Szentesi A, Bonovas S, Piovani D, Löhr JM, European PEI Multidisciplinary Group. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations. United European Gastroenterol J. 2025 Feb;13(1):125-172. doi: 10.1002/ueg2.12674. Epub 2024 Dec 5. PMID: 39639485; PMCID: PMC11866322.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.